ACEI/ARB drug therapy in COVID-19 patients: Yes or no?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ACEI/ARB drug therapy in COVID-19 patients: Yes or no?

Published:2021-03-01 Issue:1 Volume:9 Page:8-11
ISSN:2224-4018
Container-title:Journal of Translational Internal Medicine
language:en
Short-container-title:

Author:

Gong Jin¹²,Sun Yingxian³,Xie Liangdi¹²

Affiliation:

1. Department of Geriatrics, the First Affiliated Hospital, Fujian Medical University , Fuzhou , Fujian Province , China

2. Fujian Hypertension Research Institute, the First Affiliated Hospital, Fujian Medical University , Fuzhou , Fujian Province , China

3. Department of Cardiology, the First Affiliated Hospital of Chinese Medical University , Shenyang , Liaoning Province , China

Publisher

Walter de Gruyter GmbH

Subject

Internal Medicine

Link

https://www.sciendo.com/pdf/10.2478/jtim-2021-0011

Reference43 articles.

1. Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020; 579: 265-9.

2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-3.

3. Seclén SN, Nuñez-Robles E, Yovera-Aldana M, Arias Chumpitaz A. Incidence of COVID-19 infection and prevalence of diabetes, obesity and hypertension according to altitude in peruvian population. Diabetes Res Clin Pract 2020: 108463.

4. Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases(COVID-19) in China. Chin J Epidemiol 2020; 2: 145-51.

5. Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of sars coronavirus. J Virol 2020, 94: e00127-20.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncontact remote sensing of abnormal blood pressure using a deep neural network: a novel approach for hypertension screening;Quantitative Imaging in Medicine and Surgery;2023-12

2. Discontinuation of Antihypertensive Drug Use Compared to Continuation in COVID-19 Patients: A Systematic Review with Meta-analysis and Trial Sequential Analysis;High Blood Pressure & Cardiovascular Prevention;2023-05-12

3. Repurposing of RAS-Pathway Mediated Drugs for Intestinal Inflammation Related Diseases for Treating SARS-CoV-2 Infection;Current Microbiology;2023-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3